Frost & Sullivan's Premiere Industry Event: 13th Annual Medical Devices 2008: A Frost & Sullivan Executive MindXchange March 9-11, 2008 Hyatt at Fisherman's Wharf; San Francisco, CA.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Medical Devices 2008: A Frost & Sullivan Executive MindXchange - now in its thirteenth year - brings you up-to-the-minute developments in the medical devices industry and fresh perspectives on the dynamics of Industry Perspectives, Growth Strategies and Best Practices. Greg Caressi, Frost & Sullivan's Vice President of Global Healthcare, will kick off this year's event with "Your Passport to the Future of Medical Technologies." Greg will provide strategic insight into key trends and issues that are impacting the industry. He will address your top of mind concerns impacting healthcare providers, suppliers, technology development, payer and end user communities. Greg is joined by an elaborate roster of the industry's thought leaders including: * Joseph M. DeVivo, Global President, Reconstructive Orthopaedics - Smith & Nephew, Inc. * Dr. Marcus Schabacker, MD, PhD, Senior Vice President and Chief Scientific Officer - ConvaTec, A Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were Company * Peter Burke Peter Burke (born 1937) is a British historian. He was educated by the Jesuits and at St John's College, Oxford, where he obtained his doctorate. From 1962 to 1979 he was part of the School of European Studies at Sussex University, before moving to the University of Cambridge where , Vice President and Chief Technology Officer - STERIS Corporation STERIS was founded in 1987 with a venture capital investment of $1.2 million and a plan for a healthier and safer world. Today, the Company stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach * Ken Olson, Vice President, Research and Development - Medtronic Inc. * Jacob Drapkin, Vice President, Reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. & Healthcare Economics - Ethicon Endo-Surgery Ethicon Endo-Surgery, Inc., a subsidiary of Johnson & Johnson, is a company that designs and manufactures medical devices and surgical instruments with the intent of minimizing the invasiveness of surgery. Ethicon Endo-Surgery was part of Ethicon, Inc. , Inc. * Tracy Accard, Vice President, Global Research and Development, Patient Care and Safety Products - Covidien, Ltd. * Tom Oliver, Vice Chairman Makers of Game Ready - CoolSystems, Inc. * Tony Diehl, General Counsel - Insulet Corporation * Chad Fenbert, Director of Sales Owens - Corning * Les Sprinkle Senior Vice President, Orthopaedic Reconstruction - Smith & Nephew, Inc. * Annemari Cooley, Business Development Manager - Welch Allyn Welch Allyn, Inc. was founded in 1915 and is today a leading manufacturer of innovative medical diagnostic and therapeutic devices, cardiac defibrillators, patient monitoring systems, and miniature precision lamps. , Inc. * James Strommen, National Editor - Medical Device Daily To secure your registration today, or to obtain more information on the 13th Annual Medical Devices 2008: A Frost & Sullivan Executive MindXchange, please contact Brian Denker at brian.denker@frost.com or 516-255-5474 and receive a $250 discount on your registration. On Wednesday, March 12, 2008, Frost & Sullivan is proud to present its 2nd Annual Venture Connections 2008 - A Frost & Sullivan Executive Symposium: Where Venture Capitalists Venture Capitalist An investor who provides capital to either start-up ventures or support small companies who wish to expand but do not have access to public funding. Notes: Venture capitalists usually expect higher returns for the additional risks taken. Preview Emerging Stars of the Medical Devices and Life Sciences Industries. This uniquely interactive forum delivers opportunities for a critical mass of companies seeking funding to showcase their business case to the venture capital community. Presenting companies have successfully advanced through the Frost & Sullivan Investment Scorecard -- a comprehensive examination of key investment criteria - and represent the most promising investment opportunities in the Medical Devices / Life Sciences market today. Frost & Sullivan, a global growth consulting company Noun 1. consulting company - a firm of experts providing professional advice to an organization for a fee consulting firm business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a , has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics econometrics, technique of economic analysis that expresses economic theory in terms of mathematical relationships and then tests it empirically through statistical research. , and demographics. For more information, visit http://www.frost.com. FOR MORE INFORMATION For further information on Frost & Sullivan events, press/media registration, sponsorship, and inquires contact Brian Denker at brian.denker@frost.com or 516-255-5474. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion